PEPFAR's Support of American Innovation to Reach Up to 2 Million People by 2028 With Breakthrough HIV Drug Lenacapavir
September 05, 2025
September 05, 2025
WASHINGTON, Sept. 5 -- The U.S. State Department issued the following news release on Sept. 4, 2025:
* * *
PEPFAR's Support of American Innovation to Reach up to 2 Million People by 2028 with Breakthrough HIV Drug Lenacapavir
Today, the U.S. Department of State announced a market-shaping initiative by the President's Emergency Plan for AIDS Relief (PEPFAR) to bring U.S.-based Gilead Sciences' breakthrough drug lenacapavir to market in high-bu . . .
* * *
PEPFAR's Support of American Innovation to Reach up to 2 Million People by 2028 with Breakthrough HIV Drug Lenacapavir
Today, the U.S. Department of State announced a market-shaping initiative by the President's Emergency Plan for AIDS Relief (PEPFAR) to bring U.S.-based Gilead Sciences' breakthrough drug lenacapavir to market in high-bu . . .
